B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase

被引:42
作者
Meguellati, Amel [1 ,2 ]
Ahmed-Belkacem, Abdelhakim [3 ]
Yi, Wei [1 ,2 ]
Haudecoeur, Romain [1 ,2 ]
Crouillere, Marie [1 ,2 ]
Brillet, Rozenn [3 ]
Pawlotsky, Jean-Michel [3 ,4 ]
Boumendjel, Ahcene [1 ,2 ]
Peuchmaur, Marine [1 ,2 ]
机构
[1] Univ Grenoble Alpes, DPM, UMR 5063, F-38041 Grenoble, France
[2] CNRS, DPM, UMR 5063, F-38041 Grenoble, France
[3] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France
[4] Univ Paris Est, Hop Henri Mondor, Dept Virol, Natl Reference Ctr Viral Hepatitis & Delta BC, F-94010 Creteil, France
关键词
Aurones; Hepatitis C virus; RNA-dependent RNA polymerase; CRYSTAL-STRUCTURE; DISCOVERY; INFECTION; DRUGS; SITE; DERIVATIVES;
D O I
10.1016/j.ejmech.2014.04.005
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Following our recent report showing the potential of naturally occurring aurones (2-benzylidenebenzofuran-3(2H)-ones) as anti-hepatitis C virus (HCV) agents, efforts were continued in order to refine the structural requirements for the inhibitory effect on HCV RNA-dependent RNA polymerase (RdRp). In this study, we targeted the B-ring moiety of aurones with the aim to improve structural features associated with higher inhibition of the targeted polymerase. In vitro evaluation of the RdRp inhibitory activity of the 37 newly synthesized compounds pointed out that the replacement of the B-ring with an N-substituted indole moiety induced the highest inhibitory effect Of these, compounds 31, 40 and 41 were found to be the most active (IC50 = 2.3-2.4 mu M). Docking experiments performed with the most active compounds revealed that the allosteric thumb pocket I of RdRp is the binding pocket for aurone analogues. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:579 / 592
页数:14
相关论文
共 33 条
  • [1] Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus
    Ago, H
    Adachi, T
    Yoshida, A
    Yamamoto, M
    Habuka, N
    Yatsunami, K
    Miyano, M
    [J]. STRUCTURE, 1999, 7 (11) : 1417 - 1426
  • [2] Silibinin and Related Compounds Are Direct Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase
    Ahmed-Belkacem, Abdelhakim
    Ahnou, Nazim
    Barbotte, Laetitia
    Wychowski, Czeslaw
    Pallier, Coralie
    Brillet, Rozenn
    Pohl, Ralf-Torsten
    Pawlotsky, Jean-Michel
    [J]. GASTROENTEROLOGY, 2010, 138 (03) : 1112 - 1122
  • [3] [Anonymous], PYMOL MOL GRAPH SYST
  • [4] Barreca ML, 2011, FUTURE MED CHEM, V3, P1027, DOI [10.4155/fmc.11.53, 10.4155/FMC.11.53]
  • [5] Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection
    Beaulieu, Pierre L.
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (02) : 145 - 164
  • [6] Beney C, 2001, HETEROCYCLES, V55, P967
  • [7] Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus
    Bressanelli, S
    Tomei, L
    Roussel, A
    Incitti, I
    Vitale, RL
    Mathieu, M
    De Francesco, R
    Rey, FA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) : 13034 - 13039
  • [8] Structural analysis of the hepatitis C virus RNA polymerase in complex with Ribonucleotides
    Bressanelli, S
    Tomei, L
    Rey, FA
    De Francesco, R
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (07) : 3482 - 3492
  • [9] Deore RR, 2010, CURR MED CHEM, V17, P3806
  • [10] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried, MW
    Shiffman, ML
    Reddy, KR
    Smith, C
    Marinos, G
    Goncales, FL
    Haussinger, D
    Diago, M
    Carosi, G
    Dhumeaux, D
    Craxi, A
    Lin, A
    Hoffman, J
    Yu, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) : 975 - 982